Medtronic plc (MDT) — Fair Value Analysis

Base-case fair value (P50): $74.71 · Current price: $76.15 · Verdict: Fairly Valued

The Verdict on MDT

Based on our latest Monte Carlo simulations, Medtronic (MDT) is currently assessed as Fairly Valued. While the current market price sits at $77.60, our median fair value (P50) for MDT is $71.32. This indicates a -8.1% gap against the present valuation, suggesting that from a probabilistic perspective, MDT's market price is largely in line with its intrinsic fundamental value today. The discrepancy is not significant enough to warrant an "overvalued" or "undervalued" call, cementing the Fairly Valued verdict from our rigorous analysis.

How MDT stacks up against Healthcare

Within the competitive Healthcare sector, Medtronic (MDT) holds a weak quality tier. This assessment directly reflects the company’s operational and financial health when rigorously compared to its industry peers, providing crucial context for its valuation. The current market price of $77.60, relative to a median fair value of $71.32, highlights that even with a -8.1% gap, the Fairly Valued verdict is robust given these underlying quality considerations. A weaker quality tier typically implies a more constrained potential for sustained outperformance relative to its $77.60 current price, supporting the current Fairly Valued designation.

What this means for investors

For investors, MDT's Fairly Valued assessment, alongside its weak quality tier in the Healthcare sector, suggests the current $77.60 price has limited inherent undervaluation or overvaluation. The $71.32 median fair value, representing a -8.1% difference from the market, reinforces this outlook, indicating that the stock trades close to its probabilistic average. Our Monte Carlo simulations account for thousands of forward scenarios to arrive at this comprehensive probabilistic fair value. While a detailed downside scenario and an optimistic bull case are rigorously modeled, the current data indicates a balanced risk-reward profile based on the P50. To explore MDT's full bear/bull distribution and track its fair value as new fundamentals are released, sign up for FairCurve.